Singapore markets closed

Aditxt, Inc. (ADTX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
3.2500+0.2000 (+6.56%)
At close: 04:00PM EDT
3.2900 +0.04 (+1.23%)
Pre-market: 08:08AM EDT
Full screen
Trade prices are not sourced from all markets
Previous close3.0500
Open2.9200
Bid3.1800 x 1100
Ask3.3400 x 2200
Day's range2.7100 - 3.3500
52-week range2.5800 - 136.0000
Volume3,122,601
Avg. volume1,273,871
Market cap3.731M
Beta (5Y monthly)1.27
PE ratio (TTM)N/A
EPS (TTM)-1.7200
Earnings date13 Nov 2020
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est50.00
  • Business Wire

    Aditxt Inc. (Nasdaq: ADTX) Provides Corporate Highlights Post Reverse Stock Split and Closing of $20M Public Offering

    RICHMOND, Va., September 27, 2022--Aditxt, Inc. (Nasdaq: ADTX) ("Aditxt" or the "Company"), a biotech innovation company developing and commercializing technologies focused on monitoring and modulating the immune system, today provides shareholders with a corporate update following the completion of a reverse stock split and closing of a previously announced $20 million public offering.

  • Business Wire

    Aditxt Announces Closing of $20.0 Million Public Offering

    RICHMOND, Va., September 20, 2022--Aditxt, Inc., (Nasdaq: ADTX) (the "Company" or "Aditxt"), a biotech innovation company developing and commercializing technologies focused on monitoring and modulating the immune system, today announced the closing of its previously announced public offering of 3,333,333 shares of its common stock (or common stock equivalents in lieu thereof), together with warrants to purchase up to 3,333,333 shares of its common stock at a combined offering price to the publi

  • Business Wire

    Aditxt Announces Pricing of $20.0 Million Public Offering

    RICHMOND, Va., September 16, 2022--Aditxt, Inc., (Nasdaq: ADTX) (the "Company" or "Aditxt"), a biotech innovation company developing and commercializing technologies focused on monitoring and modulating the immune system, today announced the pricing of a public offering of 3,333,333 shares of its common stock (or common stock equivalents in lieu thereof), together with warrants to purchase up to 3,333,333 shares of its common stock at a combined offering price to the public of $6.00 per share (o